Trinity Biotech (NASDAQ:TRIB) Now Covered by StockNews.com
Investment analysts at StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Rating) in a research report issued on Saturday. The firm set a “buy” rating on the stock. Trinity Biotech Price Performance Shares of TRIB opened at $1.04 on Friday. Trinity Biotech has a 52 week low of $0.80 and a 52 […]